Through a follow-up medical history assessment, it was discovered that one out of five patients who exceeded the cut-off index had undergone liver resection due to hepatocellular carcinoma, and patient biochemical data revealed mild thrombocytopenia (11.3 × 104/MCL), mild elevation of transaminases (AST 45 IU/L and ALT 36 IU/L) and diabetes (hemoglobin A1c 7.1%). This evidence concerns the gene GPT and Thrombocytopenia.